These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21411801)

  • 41. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimation of creatinine clearance in morbidly obese patients.
    Demirovic JA; Pai AB; Pai MP
    Am J Health Syst Pharm; 2009 Apr; 66(7):642-8. PubMed ID: 19299371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of a divided-load intravenous vancomycin dosing strategy for obese patients.
    Denetclaw TH; Yu MK; Moua M; Dowling TC; Steinke D
    Ann Pharmacother; 2015 Aug; 49(8):861-8. PubMed ID: 25986008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.
    Bearden DT; Rodvold KA
    Clin Pharmacokinet; 2000 May; 38(5):415-26. PubMed ID: 10843460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of Vancomycin in Elderly Patients Aged over 80 Years.
    Bourguignon L; Cazaubon Y; Debeurme G; Loue C; Ducher M; Goutelle S
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4563-7. PubMed ID: 27185796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.
    Polso AK; Lassiter JL; Nagel JL
    J Clin Pharm Ther; 2014 Dec; 39(6):584-608. PubMed ID: 25203631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study.
    Donadello K; Roberts JA; Cristallini S; Beumier M; Shekar K; Jacobs F; Belhaj A; Vincent JL; de Backer D; Taccone FS
    Crit Care; 2014 Nov; 18(6):632. PubMed ID: 25416535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation.
    Hicks C; Trickett A; Kwan YL; Ramanathan S
    Ann Hematol; 2012 Nov; 91(11):1795-801. PubMed ID: 22836946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients.
    Maxson R; Pate J; Starr J
    Ren Fail; 2016 Nov; 38(10):1677-1682. PubMed ID: 27756193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation.
    Brown DL; Masselink AJ; Lalla CD
    Ann Pharmacother; 2013; 47(7-8):1039-44. PubMed ID: 23757387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.
    van Rongen A; Vaughns JD; Moorthy GS; Barrett JS; Knibbe CA; van den Anker JN
    Br J Clin Pharmacol; 2015 Nov; 80(5):1185-96. PubMed ID: 26044579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?
    Bhongsatiern J; Stockmann C; Yu T; Constance JE; Moorthy G; Spigarelli MG; Desai PB; Sherwin CM
    J Clin Pharmacol; 2016 May; 56(5):528-40. PubMed ID: 26412385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methodological Study of Vancomycin Dosing in Elderly Patients Using Actual Serum Creatinine Versus Rounded Serum Creatinine.
    Young T; Daniel M; Baumhover S; Eidson D; Green J
    Drugs R D; 2017 Sep; 17(3):435-440. PubMed ID: 28815425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the pharmacokinetics of vancomycin in neurosurgical and non-neurosurgical patients.
    Kim AJ; Lee JY; Choi SA; Shin WG
    Int J Antimicrob Agents; 2016 Oct; 48(4):381-7. PubMed ID: 27546217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Individualizing vancomycin dosing regimens: an evaluation of two pharmacokinetic dosing programs in critically ill patients.
    Fernández de Gatta MM; Fruns I; Domínguez-Gil A
    Pharmacotherapy; 1994; 14(2):196-201. PubMed ID: 8197039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Normalization of glomerular filtration rate in obese children.
    Correia-Costa L; Schaefer F; Afonso AC; Bustorff M; Guimarães JT; Guerra A; Barros H; Azevedo A
    Pediatr Nephrol; 2016 Aug; 31(8):1321-8. PubMed ID: 27008644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anesthetizing the obese.
    Green B; McLeay SC
    Anesth Analg; 2011 Jul; 113(1):1-3. PubMed ID: 21700690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.